Text Size

CANDIS-II: Evaluation of the Cognitive-behavioral Treatment Programme CANDIS

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2009 by Dresden University of Technology.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Federal Ministry of Health
Information provided by:
Dresden University of Technology
ClinicalTrials.gov Identifier:
NCT00673647
First received: May 1, 2008
Last updated: August 25, 2009
Last verified: August 2009
History of Changes

May 1, 2008
August 25, 2009
May 2008
October 2009   (final data collection date for primary outcome measure)
abstinence, defined as no evidence of cannabis use during the past 4 weeks as evidenced by self report and a negative urine screen; number of times a cannabis product was used in the past 4 weeks; retention rate [ Time Frame: at the end of treatment ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT00673647 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
CANDIS-II: Evaluation of the Cognitive-behavioral Treatment Programme CANDIS
Evaluation of the Cognitive-behavioral Treatment Programme CANDIS in the German Outpatient Treatment Service System (CANDIS-II)

The purpose of this study is to evaluate the effectiveness of the cognitive-behavioral treatment program CANDIS among n=450 patients with cannabis use disorders in a mulicenter randomized-controlled clinical trial (n=11 outpatient treatment centers).
Not Provided
Interventional
Phase 3
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
Cannabis Use Disorders
Behavioral: Cognitive-behavioral treatment
10 sessions of individual psychotherapy including cognitive-behavioral treatment, motivational enhancement and a psychosocial problem training.
Other Name: delayed treatment control group
  • Experimental: 1
    Individual psychotherapy including cognitive behavioral components, motivational interviewing techniques and case management
    Intervention: Behavioral: Cognitive-behavioral treatment
  • No Intervention: 2
    Delayed treatment control group
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
450
October 2009
October 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • motivation to change cannabis use
  • age 16 or older
  • current (12 mth) regular cannabis use (at least 2 days a week)
  • informed consent to the study procedures and assessments

Exclusion Criteria:

  • current alcohol or any illicit drug dependence syndrome according to DSM-IV other than due to cannabis
  • lifetime history of any psychotic disorder
  • current severe episode of Major depression
  • current panic-agoraphobic disorder (severe)
  • severe learning disability, brain damage or pervasive developmental disorder
  • currently acute suicidality
  • not fluent in german language
  • any other current treatment for cannabis use disorders
Both
16 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
NCT00673647
IIA5-2507DSM407
Yes
PhD Eva Hoch, Technische Universitaet Dresden
Dresden University of Technology
Federal Ministry of Health
Study Director: Hans-Ulrich Wittchen, PhD Technische Universitaet Dresden
Study Director: Gerhard Buehringer, PhD Technische Universitaet Dresden
Principal Investigator: Eva Hoch, PhD Technische Universitaet Dresden
Dresden University of Technology
August 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP